[{"NetIncomeLoss_3_Q3_USD":96182000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":1079382.0,"AssetsCurrent_0_Q3_USD":552015000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":913000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-84044000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":9700000.0,"InterestPaidNet_3_Q3_USD":2516000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":1103792.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":15366000.0,"DepreciationAndAmortization_1_Q3_USD":700000.0,"DepreciationAndAmortization_3_Q3_USD":1800000.0,"ConvertibleLongTermNotesPayable_0_Q3_USD":357521000.0,"MarketableSecuritiesCurrent_0_Q3_USD":147657000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":-3489000.0,"Liabilities_0_Q3_USD":801143000.0,"AccruedRoyaltiesCurrent_0_Q3_USD":14678000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":144377000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":54660000.0,"FinanceLeaseLiabilityNoncurrent_0_Q3_USD":19289000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"DeferredIncomeTaxAssetsNet_0_Q3_USD":0.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":1546000.0,"InterestExpenseOther_1_Q3_USD":1143000.0,"InterestExpenseOther_3_Q3_USD":3228000.0,"OtherAccountsPayableAndAccruedLiabilities_0_Q3_USD":56289000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":21019000.0,"ShareBasedCompensation_3_Q3_USD":13440000.0,"Assets_0_Q3_USD":1510022000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":535842000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":17571000.0,"CommonStockSharesIssued_0_Q3_shares":52670121.0,"IncomeTaxesPaidNet_3_Q3_USD":42284000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":21388000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":33926000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":29522000.0,"GoodwillGross_0_Q3_USD":89143000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":204293000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":6108000.0,"AccountsReceivableNetCurrent_0_Q3_USD":133107000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-603000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":2925000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":53762642.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":53663273.0,"FinanceLeasePrincipalPayments_3_Q3_USD":1056000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":32773000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-1659000.0,"EarningsPerShareBasic_1_Q3_USD":0.76,"EarningsPerShareBasic_3_Q3_USD":1.83,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":28348000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":16839000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":58023000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":2416000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":2283000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":12714000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":3217000.0,"CommonStockValue_0_Q3_USD":53000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":9814000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-1527000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":38338000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":98465000.0,"IncreaseDecreaseInInventories_3_Q3_USD":5437000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":319421000.0,"CostsAndExpenses_1_Q3_USD":98995000.0,"CostsAndExpenses_3_Q3_USD":246140000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":200000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":490000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.241,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.254,"DepreciationDepletionAndAmortization_3_Q3_USD":12621000.0,"PaymentsToAcquireOtherInvestments_3_Q3_USD":15000000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded_3_Q3_USD":0.0,"OtherAssetsNoncurrent_0_Q3_USD":18324000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_3_Q3_USD":297200000.0,"CommonStockSharesAuthorized_0_Q3_shares":130000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":376840000.0,"NonoperatingIncomeExpense_3_Q3_USD":-1745000.0,"AccountsPayableCurrent_0_Q3_USD":11193000.0,"LiabilitiesCurrent_0_Q3_USD":299606000.0,"MarketableSecuritiesNoncurrent_0_Q3_USD":388185000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":147657000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q3_USD":82900000.0,"NonoperatingIncomeExpense_1_Q3_USD":-3429000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":52658850.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":106466000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4490000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":52711000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":128955000.0,"Goodwill_0_Q3_USD":89143000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":13835000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":52583891.0,"InterestExpense_3_Q3_USD":17658000.0,"InterestExpense_1_Q3_USD":6088000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":204293000.0,"NetIncomeLoss_1_Q3_USD":39997000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":17395000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":33000000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":37941000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q3_USD":80.9063,"PaymentsToAcquireIntangibleAssets_3_Q3_USD":141000.0,"AdditionalPaidInCapital_0_Q3_USD":403396000.0,"MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_3_Q3_USD":3636000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":402265000.0,"AccruedIncomeTaxesCurrent_0_Q3_USD":0.0,"InterestExpenseDebt_1_Q3_USD":4945000.0,"InterestExpenseDebt_3_Q3_USD":14430000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":17828000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":24493000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-1659000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":2283000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":14512000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":87890000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":4490000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":13440000.0,"InventoryWorkInProcessAndRawMaterialsNetOfReserves_0_Q3_USD":9528000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":14892000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1510022000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":-280000.0,"BusinessCombinationConsiderationTransferred1_3_Q3_USD":115900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"InvestmentIncomeInterest_1_Q3_USD":3262000.0,"InvestmentIncomeInterest_3_Q3_USD":12988000.0,"InventoryNet_0_Q3_USD":42465000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_3_Q3_USD":-2538000.0,"OperatingIncomeLoss_1_Q3_USD":56140000.0,"OperatingIncomeLoss_3_Q3_USD":130700000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":155135000.0,"FinanceLeaseRightOfUseAsset_0_Q3_USD":21676000.0,"GoodwillPurchaseAccountingAdjustments_1_Q3_USD":1000000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":31907000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":8410000.0,"EarningsPerShareDiluted_1_Q3_USD":0.74,"EarningsPerShareDiluted_3_Q3_USD":1.79,"CommonStockSharesOutstanding_0_Q3_shares":52670121.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":26840000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":22912000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":295730000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q3_USD":4200000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":12351000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q3_USD":402265000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":522920000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":3234000.0,"StockholdersEquity_0_Q3_USD":708879000.0,"FinanceLeaseLiabilityCurrent_0_Q3_USD":3612000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":9304000.0,"ProfitLoss_3_Q3_USD":96182000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":3741000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":2627000.0,"Ticker":"SUPN","CIK":"1356576","name":"SUPERNUS PHARMACEUTICALS, INC.","OfficialName":"Supernus Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"1557812380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201106"}]